HRC Fertility – Fullerton

HRC Fertility – Fullerton

Since 1988, we have remained dedicated to helping hopeful parents build families through world-class assisted reproductive technology, compassion, expertise, innovation and personalized care. Reproductive Surgical Associates (RSA), our surgical center, also provides a built-in convenience for our patients from around the world as all treatments and appointments are done in one location.

Our world renowned physicians provide continuity of care to HRC patients beginning with the first consultation through graduation to their Ob/Gyn. Treatment protocols are customized for patients and HRC doctors perform all diagnostic tests, ultrasounds and IVF procedures. The journey to parenthood is a partnership truly shared between patient, doctor, and staff providing compassionate care every step of the way.

Fertility treatments we specialize in include IUI (intrauterine insemination), IVF (in vitro fertilization), PGT (Preimplantation Genetic Testing), Single Embryo Transfer (SET), Gender Selection, family building options for the LGBT community, egg freezing and 3rd party parenting programs such as egg donation and surrogacy. We also have extensive programs for male factor infertility and “unexplained infertility.”

“We’re excited to welcome USC Fertility to HRC Fertility,” says Sherif Hanna, CEO of HRC Fertility Management. “Adding the ability to explore new scientific breakthroughs and work with the next generation of fertility specialists allows us to continue to transform and shape the future of treating and caring for patients who experience infertility.”

“USC Fertility is committed to providing our patients with cutting-edge, evidence-based medical care,” added Richard J. Paulson, MD, director of USC Fertility, professor of obstetrics and gynecology and chief of the Division of Reproductive Endocrinology and Infertility with the Keck School. “We will continue to provide this high level of care and look forward to expanding our capabilities and additional contributions to research to advance the standard of fertility treatment.”